CRP and major depressive disorder: Patients with MDD who show increased levels of serum pro-inflammatory cytokines, including C-reactive protein (CRP), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and IL-1β, had a poor response to conventional antidepressant therapies (15–18).